Overview

Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.

Status:
Not yet recruiting

Trial end date:
2024-02-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and safety of Berlim 25/20 association in the treatment of type 2 diabetes mellitus and dyslipidemia.

Phase:

Phase 3

Details

Lead Sponsor:

EMS

Treatments:

Calcium
Calcium, Dietary
Empagliflozin
Rosuvastatin Calcium